biologics

News

Sanofi opens $595m manufacturing facility in Singapore

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products

News

Dr Deborah Bitterfield, chief executive and founder of Lindy Biosciences

Push for self-injected drugs prompts Novartis/Lindy alliance

Novartis is putting $20 million upfront into a near-$1 billion deal with US start-up Lindy Biosciences that aims to convert biologic drugs delivered by infusion into therapies that can be s

News

Bill that would cut down ‘patent thickets’ clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.

News

Sanofi to invest €1bn in France to lift ‘health sovereignty’

Sanofi will invest more than €1 billion ($1.08 billion) in new bioproduction capacity at three manufacturing sites in France as part of a €3.5 billion programme in the cou

News

Lonza adds biologics capacity with $1.2bn Roche deal

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part o

News